Inventor · disambiguated record
Aravind Asokan
Also filed as: ASOKAN ARAVIND
21 granted patents·15 pending applications·372 citations·filing 2007–2024
95Inventor score
Files withUNIV NORTH CAROLINA CHAPEL HILL18UNIV DUKE12ASOKAN ARAVIND2ISOLERE BIO INC1UNIV INDIANA RES & TECH CORP1
Top patents by PatentIndex Score
36 records- 0198US9475845B2Modified virus vectors and methods of making and using the sameUNIV NORTH CAROLINA CHAPEL HILL·Filed 2014·Granted Oct 25, 2016·76 cites·8 claims
- 0296US8889641B2Modified virus vectors and methods of making and using the sameASOKAN ARAVIND·Filed 2010·Granted Nov 18, 2014·73 cites·4 claims
- 0396US7867484B2Heparin and heparan sulfate binding chimeric vectorsUNIV NORTH CAROLINA·Filed 2007·Granted Jan 11, 2011·51 cites·35 claims
- 0495US11208438B2Methods and compositions for antibody-evading virus vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Granted Dec 28, 2021·5 cites·24 claims
- 0593US10077291B2Methods and compositions for dual glycan binding AAV vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2014·Granted Sep 18, 2018·15 cites·21 claims
- 0692US12466860B2Methods for using dual glycan binding AAV vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Granted Nov 11, 2025·0 cites·16 claims
- 0792US10745447B2Methods and compositions for antibody-evading virus vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Aug 18, 2020·8 cites·33 claims
- 0892US9409953B2Viral vectors with modified transduction profiles and methods of making and using the sameASOKAN ARAVIND·Filed 2012·Granted Aug 9, 2016·126 cites·20 claims
- 0989US11840555B2Methods and compositions for antibody-evading virus vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2021·Granted Dec 12, 2023·1 cites·24 claims
- 1089US10907176B2Methods and compositions for targeted gene transferUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Feb 2, 2021·8 cites·39 claims
- 1188US2024327468A1Methods and compositions for dual glycan binding aav vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
- 1287US11718862B2Methods and compositions for circular RNA moleculesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2021·Granted Aug 8, 2023·2 cites·28 claims
- 1386US12037598B2Cross-species compatible adeno-associated virus compositions and methods of use thereofUNIV DUKE·Filed 2023·Granted Jul 16, 2024·1 cites·20 claims
- 1485US10585103B2Methods and compositions for resolving components of a virus preparationUNIV INDIANA RES & TECH CORP·Filed 2017·Granted Mar 10, 2020·4 cites·20 claims
- 1581US2024158450A1Methods and compositions for antibody-evading virus vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2023·Application pending·0 cites
- 1678US12146151B2Cross-species compatible adeno-associated virus compositions and methods of use thereofUNIV DUKE·Filed 2023·Granted Nov 19, 2024·0 cites·20 claims
- 1777US12049478B2Methods and compositions for dual glycan binding AAV vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Granted Jul 30, 2024·0 cites·25 claims
- 1877US11717560B2Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseasesUNIV DUKE·Filed 2021·Granted Aug 8, 2023·1 cites·17 claims
- 1972US11905312B2Methods and compositions for gene transfer across the vasculatureUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted Feb 20, 2024·1 cites·11 claims
- 2072US11059862B2Methods and compositions for dual glycan binding AAV vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted Jul 13, 2021·0 cites·24 claims
- 2172US2024141379A1Methods and compositions for circular rna moleculesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2023·Application pending·0 cites
- 2269US2024209031A1Methods and compositions for gene transfer across the vasculatureUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
- 2362US2024124878A1Compositions for and methods of engineering the transcriptomeUNIV DUKE·Filed 2022·Application pending·0 cites
- 2461US12508305B2Compositions and methods for treating and/or preventing glycogen storage disease type IIIUNIV DUKE·Filed 2021·Granted Dec 30, 2025·0 cites·9 claims
- 2556US2023203508A1Methods and compositions for circular rna moleculesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Application pending·0 cites
- 2656US2025195693A1Compositions Comprising Adeno-Associated Virus Chimera Capsid Proteins and Methods of Using the SameUNIV DUKE·Filed 2022·Application pending·0 cites
- 2755US12281320B2Methods and compositions for antibody-evading virus vectorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Granted Apr 22, 2025·0 cites·18 claims
- 2855US2024366788A1Adeno-associated virus compositions and methods of use thereofUNIV DUKE·Filed 2022·Application pending·0 cites
- 2954US2024226338A9Compositions For and Methods of Improving Gene TherapyUNIV DUKE·Filed 2022·Application pending·0 cites
- 3054US2022143213A1Composition and Methods for Evading Humoral ImmunityUNIV DUKE·Filed 2020·Application pending·0 cites
- 3154US2024082351A1Compositions for and methods of improving fluid flux in the brainUNIV DUKE·Filed 2022·Application pending·0 cites
- 3252US2024294576A1Compositions and methods for formation and secretion of extracellular vesicles and aav particlesUNIV DUKE·Filed 2021·Application pending·0 cites
- 3351US2025319204A1Compositions for and methods of treating and/or preventing glycogen storage disease type vi and type ixUNIV DUKE·Filed 2021·Application pending·0 cites
- 3449US2023348863A1Purification matrices comprising aav-binding polypeptides and methods of using the sameISOLERE BIO INC·Filed 2021·Application pending·0 cites
- 3547US11214779B2Activatable CRISPR/CAS9 for spatial and temporal control of genome editingUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Jan 4, 2022·0 cites·10 claims
- 3647US2021147487A1Methods and compositions for engineered assembly activating proteins (eaaps)UNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aravind Asokan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →